Ajulemic Acid (CAS 137945-48-3): Properties, Applications, and Research Insights

Exploring the potent anti-inflammatory and analgesic effects of this synthetic cannabinoid analog for therapeutic applications.

Get a Quote & Sample

Key Advantages

Non-Psychoactive Profile

Ajulemic acid's minimal CB1 receptor affinity translates to a lack of psychoactive effects, distinguishing it from traditional cannabinoids and improving patient tolerability in pain management applications.

Therapeutic Versatility

Its anti-inflammatory and anti-fibrotic properties make it suitable for a range of inflammatory diseases, as evidenced by ongoing research and Ajulemic acid clinical trials.

Favorable Pharmacokinetics

The compound demonstrates minimal CYP450 metabolism, reducing the risk of drug-drug interactions and offering a more predictable therapeutic profile compared to other cannabinoids.

Key Applications

Pain Management

Ajulemic acid's potent analgesic properties are explored for chronic pain conditions, offering an alternative to traditional pain relievers with a better safety profile, as seen in Ajulemic acid analgesic anti-inflammatory effects studies.

Inflammatory Diseases

Research into Ajulemic acid focuses on its ability to treat conditions like arthritis, dermatomyositis, and systemic lupus erythematosus by reducing inflammation and tissue damage.

Fibrosis Treatment

The anti-fibrotic effects of Ajulemic acid make it a candidate for treating conditions involving tissue scarring, such as pulmonary fibrosis and systemic sclerosis.

Research Tool

Its unique interaction with PPAR-gamma and cannabinoid receptors makes it a valuable tool in pharmacological research aimed at understanding inflammatory pathways and developing new therapeutic agents.